Differential Effects of Maternal and Fetal Betamethasone Injections in Late-Gestation Fetal Sheep

Abstract

Objective: To determine the effects of single or repeated intramuscular injections of betamethasone, given maternally or directly to the fetus, on chronically catheterized, late-gestation fetal sheep. Methods: Fetal or maternal sheep received either repeated intramuscular injections of betamethasone (0.5 mg/kg body weight at 104, 111, and 118 days' gestation), single betamethasone injection (at 104 days' gestation, followed by saline at 111 and 118 days' gestation), or repeated saline injection; n = 6 or 7 per group. At approximately 130 days' gestation fetuses were catheterized for serial measurements of heart rate, arterial pressure, blood gases, metabolites, and electrolytes. Results: Repeated maternal betamethasone injections reduced birth weight (P = .03) without fetal hypoxemia or hypoglycemia. Circulating fetal calcium and lactate concentrations were reduced (P = .002 and P = .014, respectively) by repeated maternal betamethasone only. Fetal hematocrit tended to be lower after fetal (P = .3) and matenal (P = .07) betamethasone. Conclusion: Growth restriction caused by repeated maternal betamethasone treatments is not due to overt chronic placental insufficiency but may be caused by alterations in hormonal mediators of fetal growth or impairment of placental transport of specific nutrients.

Keywords

Antenatal corticosteroids intrauterine growth restriction placenta

Get full access to this article

View all access options for this article.

References

1. National Institutes of Health Consensus Development Panel . Antenatal corticosteroids revisited: Repeat courses—National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol 2001;98:144-150.

2. Crowley P . Prophylactic corticosteroids for preterm birth. Cochrane Database of Systematic Reviews 2002;1-1.

3. Quinlivan JA , Evans SF , Dunlop SA , Beazley LD , Newnham JP . Use of corticosteroids by Australian obstetricians-A survey of clinical practice. Aust N Z J Obstet Gynecol 1998;38:1-7.

4. Newnham JP , Moss TJ . Antenatal glucocorticoids and growth: Single versus multiple doses in animal and human studies. Semin Neonatol 2001;6:285-292.

5. Aghajafari F , Murphy K , Matthews S , Olson A , Amankwah K , Hammah M . Repeated doses of antenatal corticosteroids in animals: A systemic review. Am J Obstet Gynecol 2002;186:843-849.

6. Fench NP , Hagan R , Evans SF , Godfrey M , Newnham JP . Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-121.

7. Banks BA , Cnaan A , Morgan MA , et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am J Obstet Gynecol 1999;181:709-717.

8. Walfish A , Hallak M , Mazor M . Multiple courses of antenatal steroids: Risks and benefits. Obstet Gynecol 2001;98:491-497.

9. Aghajafari F , Murphy K , William A , et al. Multiple courses of antenatal corticosteroids: A systematic review and meta-analysis. Am J Obstey Gynecol 2001;185:1073-1080.

10.

10. Elimian A , Verma U , Visintainer P , Tejani N . Effectiveness of multidose antenatal steroids. Obstet Gynecol 2000;95:34-36.

11.

11. Thorp JA , Jones AMH , Hunt C , Clark R . The effect of multidose antenatal betamethasone on maternal and infant outcomes. Am J Obstet Gynecol 2001;184:196-202.

12.

12. Shelton SD , Boggess KA , Murtha AP , Groff AO , Herbert WNP . Repeated fetal betamethasone treatment and birth weight and head circumstance. Obstet Gynecol 2001;97:301-304.

13.

13. Newnham JP , Evans SF , Godfrey M , Huang W , Ikegami M , Jobe A . Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J Matern Fetal Med 1999;8:81-87.

14.

14. Moss TJM , Sloboda DM , Gurrin LC , Harding R , Challis JRG , Newnham JP . Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol 2001;281:R960-R970.

15.

15. Berry LM , Polk DH , Ikegami M , Jobe AH , Padbury JF , Ervin MG . Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am J Physiol 1997;272:R1972-R1979.

16.

16. Rebello CM , Ikegami M , Polk DH , Jobe AH . Postnatal lung responses and surfactant function after fetal or maternal corticosteroid treatment. J Appl Physiol 1996;80:1674-1680.

17.

17. Bauer MK , Harding JE , Bassett NS , et al. Fetal growth and placental function. Mol Cell Endocrinol 1998;140:115-120.

18.

18. Fowden A . Growth and metabolism. In: Harding R , Bocking A , eds. Fetal growth and development. Cambridge: Cambridge University Press, 2001;44-69.

19.

19. Newnham JP , Polk DH , Kelly RW , et al. Catecholamine response to ultrasonographically guided percutaneous blood sampling in fetal sheep. Am J Obstet Gynecol 1994;171:460-465.

20.

20. Lima M , Kallfelz F , Krook L , Nathanielsz P . Humeral skeletal development and plasma constituent changes in fetuses of ewes maintained on a low calcium diet from 60 days of gestation. Calcif Tissue Int 1993;52:283-290.

21.

21. Hosking DJ . Calcium homoestasis in pregnancy. Clin Endocrinol 1996;45:1-6.

22.

22. Kovacs CS , Ho-Pao CL , Hunzelman JL , et al. Regulation of murine fetal- placental metabolism by the calcium-sensing receptor. J Clin Invest 1998;101:2812-2820.

23.

23. Glatz J , Heath J , Southby J , et al. Dexamethasone regulation of parathyroid hormone-related protein (PTHrP) expression in a squamous cancer cell line. Mol Cell Endocrinol 1994;101:295-306.

24.

24. Rizzoli R , Feyen J , Grau G , Wohlwend A , Sappino A , Bonjour J . Regulation of parathyroid hormone-related protein production in a human lung squmous cell carcinoma line. J Endocrinol 1994;143:333-341.

25.

25. Liu B , Goltzman D , Rabbani S . Regulation of parathyroid hormone-related peptide production in vitro by the rat hypercalcemic Leydig cell tumor H-500. Endocrinology 1993;132:1658-1664.

26.

26. Dvir R , Golander A , Jaccard N , et al. Amniotic fluid and plasma levels of parathyroid hormon-related protein and hormonal modulation of its secretion by amniotic fluid cells. Eur J Endocrinol 1995;133:272-274.

27.

27. Paspaliaris V , Petersen DN , Thiede MA . Steroid regulation of parathyroid hormone- related protein expression and action in the rat uterus. J Steroid Biochem Mol Biol 1995;53:259-265.

28.

28. Mosier HD , Dearden LC , Roberts RC , Jansons RA , Biggs CS . Regional differences in the effects of glucocorticoids on maturation of the fetal skeleton in rats. Teratology 1981;23:15-24.

29.

29. Jensen EC , Gallaher BW , Breier BH , Harding JE . The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep 2002;174:27-36.

30.

30. Moss T , Nitsos I , Harding R , Newnham J . The acute and longer-term differential effects of maternal and fetal betamethasone treatments in chronically catheterised sheep. Czech Gynecol 2002;67:4-4.

31.

31. Westgren M , Kruger K , Ek S et al. Lactate compared with pH analysis at fetal scalp blood sampling: A prospective randomised study. Br J Obstet Gynaecol 1998;105:29-33.

32.

32. Kruger K , Hallberg B , Blennov M , Kublickas M , Westgren M . Predictive value of fetal scalp blood lactate concentration and pH as markers of neurologic disability. Am J Obstet Gynecol 1999;181:1072-1078.

33.

33. Jobe AH , Wada N , Berry LM , Ikegami M , Ervin MMG . Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 1998;178:880-885.

34.

34. Moritz KM , Lim GB , Wintour EM . Developmental regulation of erythropoietin and erythropoiesis. Am J Physiol 1997;273:R1829-R1844.

35.

35. Roodman G , Lee J , Gidari A . Effects of dexamethasone on erythroid colony and burst formation from human fetal liver and adult marrow. Br J Haematol 1983;53:621-628.

36.

36. Wintour E , Clemons G , Butkus A , Horvath A , Moritz K , Towstowless M . Immunoreactive erythropoietin concentration and haemoglobin type in the perinatal period in sheep of various haemoglobin genotypes. J Dev Physiol 1990;14:259-265.